CPR Invest - Biodiversity - R EUR - Acc ISIN : LU3133798929

CPR Invest - Biodiversity - R EUR - Acc
R EUR(C) - LU3133798929
Asset class: Equities

YTD
-

Risk IndicatorThe level of risk of the fund mainly reflects the risk of the market in which the fund is invested and, as the case may be, the leveraging strategy or inverse performance of the index. The capital initially invested does not benefit from any guarantee. The current level of risk does not indicate the future level of risk and may change over time. The lowest risk level is not equal to a risk-free investment.
1234567
Lower Risk
Higher Risk
The risk indicator assumes you keep the product according to the holding period.

NAV
-

SFDR ClassificationSustainable Finance Disclosure Regulation
Art. 8

Fund AUM
-
The Compartment's objective is to outperform the MSCI World Index, over the recommended holding period (at least five years) through active management of international equities, while incorporating indicators for analysing the sustainability of biodiversity practices.

NAVs

NAV from 20/11/2026 to 01/01/1970
Select period
Data range not available

Performance

Change in NAV in base 100
FundCPR Invest - Biodiversity - R EUR - Acc (0% over the period)
Select period
Data range not available
FundCPR Invest - Biodiversity - R EUR - Acc (0% over the period)
Select period
Data range not available

Portfolio Analysis

Repartition 10/31/2026
Created with Highcharts 11.4.8Values32.87​32.8717.41​17.4115.67​15.6711.31​11.317.60​7.605.37​5.372.89​2.892.71​2.711.50​1.501.18​1.1830.72​30.7210.75​10.7516.03​16.039.95​9.958.60​8.607.12​7.125.21​5.212.45​2.453.14​3.141.57​1.57PortfolioBenchmark024681012141618202224262830323436Information TechnologyIndustrialsFinancialsHealth CareConsumer DiscretionaryCommunication ServicesConsumer StaplesUtilitiesMaterialsReal EstateHighcharts.com

Management commentary

Effective date: 31/10/2026Key highlights of the month
October 2026 was marked by a strong rotation out of AI-related growth stocks and into more defensive, profitable assets that are less exposed to valuation risk. The Nasdaq-100 lost 6.7%, while the equal-weighted S&P 500 rose by about 5%, signaling a clear broadening of the market. Earnings releases from Alphabet, Microsoft, and Intel crystallized doubts about the sustainability of the AI capex boom: Alphabet saw a sharp correction after disappointing results in traditional search and a negative free cash flow, Microsoft raised its expected capex, and Intel suffered from disappointing guidance. At the same time, geopolitical tensions in the Middle East, the rebound and subsequent volatility in oil prices, and a more hawkish Fed than anticipated maintained a cautious climate, even though the 10-year Treasury yield eventually fell back to 4.9% at the end of the month.
The month clearly favored Value and Quality styles. The best-performing factors were those related to cash flow and valuation multiples, confirming investors’ renewed focus on companies capable of generating tangible cash. Conversely, growth and momentum factors suffered, reflecting the breakdown of outperformance among the most expensive and consensus AI stocks. Quality factors also held up well in an environment of heightened credit tensions.
Note:
On October 31, 2026, COP17 adopted a decisive agreement, the “Yerevan Pathway,” to accelerate measures conducive to achieving the 23 targets of the Global Biodiversity Framework (GBF) by 2030. The assessment is that states are lagging: of the 23 targets, only one is on track to be achieved by 2030. Four priority actions have emerged to focus on by 2030: 1) combating subsidies and incentives harmful to nature, 2) increasing financial, scientific, and technical support to developing countries, 3) aligning national budgets and economic decisions with the global biodiversity framework, and 4) strengthening implementation, monitoring, and reporting mechanisms.
 
Summary of the main positions of the month:
In October 2026, the fund posted an underperformance relative to its benchmark.
This relative underperformance is mainly explained by the absence of the energy sector, which saw a marked increase this month. US technology stocks also suffered, with the Nasdaq falling by 6%, which weighed on the growth stocks held in the portfolio. Despite these headwinds, the fund benefited from the strong performance of the healthcare and defensive sectors, which helped limit the gap with the benchmark.
The most significant performance drivers were strong earnings in healthcare, notably Biogen (+14%) and Gilead Sciences (+17%), as well as the rebound of defensive stocks such as Veolia and Badger Meter (+22%). Stock selection in software worked well with Autodesk (+21%), a position we are maintaining for its exposure to eco-design and natural risk simulation tools, particularly related to water and cities, as well as Synopsys (+9%). The absence of Meta Platforms (-14%) for ESG reasons benefited the fund.
Conversely, ServiceNow (-20%) and Xylem (-7%) suffered sharp corrections following broker downgrades and disappointing earnings releases, causing temporary volatility. In addition, environmental and biodiversity exclusions (Tesla +14%, Eli Lilly +24%) resulted in missed gains, consistent with the fund’s philosophy but at the expense of performance.
 
Outlook for the following month:
Portfolio management remained cautious, with reduced risk and few major moves. Veolia was increased after its decline, in line with a strong defensive and environmental rationale. Positions in ServiceNow and Xylem were maintained despite volatility, reflecting conviction in the potential of these stocks. Biodiversity exclusions continued, even though they cost performance this month. Finally, the fund is actively monitoring developments related to artificial intelligence, particularly the IPO of Anthropic, which could influence sector allocation in the medium term.
In conclusion, the fund remains positioned in growth and quality stocks, while maintaining prudent management in an unfavorable sector rotation environment. In a context marked by high interest rates, massive financing needs around AI, and persistent energy tensions, the priority remains the robustness of holdings and control of the benchmark gap. On the extra-financial front, the COP mainly confirmed the lag of states, while companies continue to make progress through TNFD reporting and engagement.

Characteristics

General data

Inception date
20/10/2025
First Nav Date
Currency
EUR
Show more
Valuation
Daily
Minimum initial investment
1 10/1000° share(s)/equity
Minimum additional investment
1 10/1000° share(s)/equity

Costs Composition

One-off costs upon entry or exit (Investment EUR 10,000)If you exit after 1 year
Entry costsThis includes distribution costs of 5.00% of amount invested. This is the most you will be charged. The person selling you the product will inform you of the actual charge.Up to €500.00
Exit costsWe do not charge an exit fee for this product, but the person selling you the product may do so.€0.00
Ongoing costs taken each year (Investment EUR 10,000)
Management fees and other administrative or operating costs1.05% of the value of your investment per year. This percentage is based on actual costs over the last year.€99.75
Transaction costs0.20% of the value of your investment per year. This is an estimate of the costs incurred when we buy and sell the underlying investments for the product. The actual amount will vary depending on how much we buy and sell.€19.00
Incidental costs taken under specific conditions (Investment EUR 10,000)
Performance fees

15.00% annual outperformance of the reference asset 100% MSCI WORLD NR Close. The calculation applies on each Net Asset Value calculation date in accordance with the terms described in the prospectus. Past underperformances over the last 5 years should be clawed back before any new accrual of performance fee.The actual amount will vary depending on how well your investment performs. The aggregated cost estimation above includes the average over the last 5 years.

The performance fee is paid even if the performance of the share over the performance observation period is negative, while remaining higher than the performance of the Reference Asset.

€0.00

Codification

ISIN code
LU3133798929
Bloomberg code
CPIBRER LX
Reuters code

Investment Objective

The Compartment's objective is to outperform the MSCI World Index, over the recommended holding period (at least five years) through active management of international equities, while incorporating indicators for analysing the sustainability of biodiversity practices.

Documents

LanguageDocumentsTypeClosing Date
FR
PDF
01/09/2026
PDF
31/07/2025
PDF
03/08/2026
PDF
31/01/2026
FR
PDF
28/04/2026
PDF
31/10/2026
PDF
31/12/2024
PDF
31/03/2025
FR
PDF
26/10/2016
This site does not constitute in any way a solicitation or an offer to buy or sell securities. The information it contains is intended to inform the subscriber by supplementing certain financial characteristics of the OPC appearing in the Key Information Document (KID PRIIPs) or in the prospectus. As a result, this information is inevitably partial and is subject to change. The KID PRIIPs or the prospectus must be offered to subscribers prior to subscription, provided upon subscription and made available to the public upon request, as well as the latest financial statements available.
Data relating to past performance does not take into account any entry fees and exit fees on subscriptions and redemptions of units. These fees may impact past performance.
The funds and securities mentioned above are in no way sponsored, recommended or promoted by the sponsor of the reference index or benchmark used. The sponsor of the reference index or benchmark is not legally and legally responsible for the funds, securities, indices or any funds or securities on which these are based.
References of the local representative or paying agent from whom the legal documents are available free of charge: CACEIS Bank France 1-3, place Valhubert 75013 Paris.